Cite
Schwarz UI, Hanso H, Oertel R, et al. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther. 2007;81(5):669-78doi: 10.1038/sj.clpt.6100191.
Schwarz, U. I., Hanso, H., Oertel, R., Miehlke, S., Kuhlisch, E., Glaeser, H., Hitzl, M., Dresser, G. K., Kim, R. B., & Kirch, W. (2007). Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clinical pharmacology and therapeutics, 81(5), 669-78. https://doi.org/10.1038/sj.clpt.6100191
Schwarz, U I, et al. "Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol." Clinical pharmacology and therapeutics vol. 81,5 (2007): 669-78. doi: https://doi.org/10.1038/sj.clpt.6100191
Schwarz UI, Hanso H, Oertel R, Miehlke S, Kuhlisch E, Glaeser H, Hitzl M, Dresser GK, Kim RB, Kirch W. Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol. Clin Pharmacol Ther. 2007 May;81(5):669-78. doi: 10.1038/sj.clpt.6100191. Epub 2007 Mar 28. PMID: 17392718.
Copy
Download .nbib